Tatva CHIN Pharm CHEM LTD

Tatva Chin Pharm Chem Ltd (TATVA) is a micro-cap Chemicals company valued at ₹4,547 crore operating in Specialty Chemicals on the NSE and BSE.

Recent price move

Tatva Chin Pharm Chem Ltd last traded at ₹1,932.3, modestly down 0.43% on the day.

Recent developments

On 2026-09-11, the company announced a dividend of ₹2.00 per share, ex-date. Promoter holding remained at 72.02% as of 2026-06-30, while foreign institutional holding increased by 0.11 points and domestic institutional holding rose by 0.12 points in the quarter.

Financial performance

The company's business has improved significantly, with annual revenue rising 32.1% and net profit surging 600.8% year-over-year. The latest quarter showed even stronger growth, with revenue up 42.8% and net profit jumping 128.3% compared to the same quarter a year earlier. However, the 3-year profit CAGR of -2.2% and 5-year CAGR of -4.2% suggest a slowdown in profitability over longer periods.

Valuation multiples

The stock trades at 107.5 times earnings, 4.98 times book value. It yields 0.1%.

Things to watch

The stock is 7.3% below its 52-week high, and the 5-year profit CAGR of -4.2% indicates a decline in profitability over the past five years. The return on equity of 5.4% and return on capital employed of 6.6% are relatively low, suggesting limited efficiency in generating returns for shareholders.

Where it stands

The company has delivered strong growth in both revenue and net profit in the latest quarter and year-over-year, with net profit margin improving by 6.7 percentage points. The most significant movement was the 600.8% rise in annual net profit. The stock remains 7.3% below its 52-week high.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.